Department of General Medicine and Primary Care, University of Tsukuba Hospital, Ibaraki (Dr. Maejima); Department of Medical Education Studies, International Research Center for Medical Education, Graduate School of Medicine, The University of Tokyo (Dr. Mizumoto); Department of Internal Medicine, Tokatsu Hospital, Chiba (Dr. Ito); Department of Endocrinology and Metabolism, TMG Asaka Medical Center, Saimata (Dr. Suga), Japan t.maejima.2019@gmail.com
The authors reported no potential conflict of interest relevant to this article.
The patient was discharged on Day 28. After discharge, she took propylthiouracil as prescribed (300 mg/d), and her Graves disease was well controlled. Outpatient follow-up visits were performed every 1 or 2 months. No adverse events of propylthiouracil were seen in the ensuing time.
THE TAKEAWAY
Patients with chronic conditions sometimes discontinue medications, and they may not talk about it with their medical team, especially if they have socioeconomic or other difficulties in their lives. Clinicians should consider medication nonadherence and its risk factors when patients with chronic conditions develop unexpected adverse events.
ACKNOWLEDGMENT We thank Jane Charbonneau, DVM, from Edanz for doing an English-language review of a draft of this manuscript.
CORRESPONDENCE Takuya Maejima, MD, Department of General Medicine and Primary Care, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576 Japan; t.maejima.2019@gmail.com
